Login / Signup

Impact of frailty on the management of patients with gynecological cancer aged 80 years and older.

Elisabeth ReiserNina PötschVeronika SeebacherAlexander ReinthallerFriedrich WimazalEdith FleischmannMichael KrainerReinhart HorvatStephan PolterauerChristoph Grimm
Published in: Archives of gynecology and obstetrics (2020)
Majority of patients was able to receive standard therapy, as suggested by the tumor board, irrespective of age and frailty. Nonetheless, frailty is a common finding in patients with gynecological malignancy aged 80 years and older. Frail patients show shorter progression-free, and overall survival within this cohort.
Keyphrases